Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Ypsomed Holding AG, headquartered in Switzerland (CH), is a leading developer and manufacturer of innovative injection and infusion systems for self-medication. The company specializes in solutions for diabetes management, featuring advanced pen systems and insulin pumps. Ypsomed provides pharmaceutical companies with technologies for safe drug delivery, enhancing the quality of life for patients globally.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Ypsomed Holding is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Ypsomed Holding last reported quarterly earnings on 5/20/2026 (Q1 2026). Earnings per share (EPS) came in at 6.11 CHF.
For fiscal year 2026, Ypsomed Holding paid a dividend of 4.40 CHF per share.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
| Fiscal year | Dividend per share |
|---|---|
| 2026 | 4.40 CHF |
| 2025 | 2.20 CHF |
| 2024 | 2.00 CHF |
| 2023 | 1.30 CHF |
| 2022 | 0.60 CHF |
Source: Ypsomed Holding investor relations, 5 fiscal years.
Past dividends are no guarantee of future payouts.